What's New in the Management of Eosinophilic Esophagitis: Working Together to Integrate Targeted Treatment Options Into Practice
What's New in the Management of Eosinophilic Esophagitis: Working Together to Integrate Targeted Treatment Options Into Practice is organized by PVI, PeerView Institute for Medical Education.
Activity Release Date: February 21, 2023
Activity Expiration Date: February 20, 2024
Activity Description:
Eosinophilic esophagitis (EoE) is a chronic allergic type 2 inflammatory disease characterized by a clinical and pathologic phenotype of progressive esophageal dysfunction due to tissue inflammation and fibrosis. Diagnosis of EoE is frequently missed or delayed, which can lead to such complications as esophageal stricture and reduced patient quality of life.
Fortunately, targeted biologic therapies already approved for other type 2 inflammatory disorders are approved, or are in development, for the treatment of EoE and appear promising.
This case-based activity will offer expert insights for recognizing and diagnosing EoE, monitoring and managing EoE, and integrating targeted therapies into practice.
Educational Objectives:
Upon completion of this activity, participants should be better able to:
- Diagnose eosinophilic esophagitis (EoE) promptly according to the latest guidelines and criteria to decrease the risk of complications precipitated by uncontrolled disease
- Apply the latest clinical research developments and updates in treatment guidelines to the management of EoE in collaboration with the healthcare team
- Select treatment, including novel targeted biologic therapies, for patients with EoE based on the latest clinical evidence